E. coli Testing Market projected to expand at a CAGR of 7.5% from 2019 to 2027

Transparency Market Research (TMR) has published a new report titled, ‘E. coli Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the report, the Global E. coli Testing Market was valued at US$ 1,380.0 Mn in 2018 and is projected to expand at a CAGR of 7.5% from 2019 to 2027.


  • E.coli are a type of coliform bacteria and is found in the intestines of warm-blooded animals, including humans.
  •  North America dominated the Global E. coli Testing Market in 2018 and the trend is anticipated to continue during the forecast period. . The U.S. dominated the market in North America due to adoption of new technologies such as next generation sequencing along with higher awareness, significant health care spending in overall national budgets, early availability of advanced technologies, and higher penetration of research activities across the country.
  •  Asia Pacific is likely to be a highly lucrative market for E. coli infections and it is expected to expand at a high CAGR during the forecast period. The market is supported by rapidly growing hospitals and diagnostic centers in developed countries such as China and India, which in turn is expected to increase the demand for water testing kits in accordance with the growth of the E. coli testing market.

 Request Brochure for Report -

High morbidity and rapid spread of E. coli augment the market growth to Drive Market

  • Water and foodborne diseases are on the rise globally, especially in underdeveloped and developing nations. E. coli has been identified as one of the major causative organisms of water and foodborne diseases.
  • Prevalence of diarrhea and hemolytic uremic syndrome (HUS) is increasing rapidly across the world. These are mostly caused by E. coli infections.
  • In addition, epidemic of E. coli infections in Germany during 2011 had spread to various parts of the world (more than 10 countries), including the U.S., the U.K., Spain, and France. Moreover, countries in the WHO European region have reported significant number of infections caused due to verocytotoxin-producing E. coli O104:H4 strains.
  • Various environmental as well as clinical samples are tested regularly to identify E. coli contamination and take preventive measures, especially during epidemics, in order to stop the spread of infections. Therefore, rapid increase of water and foodborne E. coli diseases has boosted the demand for E. coli testing globally.

 Request for Analysis of COVID19 Impact on E. coli Testing Market –

Combination Pills Segment to Dominate Market

  • Based on type, the Global E. coli Testing Market has been divided into combination pills, progestin-only pills, and others (ormeloxifene and mifepristone). The combination pills segment has been bifurcated into monophasic, triphasic and others (biphasic, quadriphasic). The combination pills segment dominated the Global E. coli Testing Market in 2018 and the trend is projected to continue during the forecast period. Increase in use of combination pills to accelerate the growth of the segment. Increase in the popularity of monophasic combination pills is also major factor for to boost the market growth. Low estrogen monophasic pills cause less bloating or breast tenderness. Hence, most women consider monophasic pill as a first line of choice for contraception.
  • Moreover, fewer side effects, optimum price of the pills, and higher efficacy makes it preferable for use among women

 Buy E. coli Testing Market Report -

North America to Dominate Global Market

  • In terms of region, the Global E....

Do you already have an account? Log in here

Posted in: Africa

Join the discussion


To read and post comments you need to login or register